INDEMNITY AGREEMENTIndemnity Agreement • September 9th, 2015 • Anaptysbio Inc • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 9th, 2015 Company Industry JurisdictionThis Indemnity Agreement, dated as of , 2015 is made by and between AnaptysBio, Inc., a Delaware corporation (the “Company”), and , a director, officer or key employee of the Company or one of the Company’s subsidiaries or other service provider who satisfies the definition of Indemnifiable Person set forth below (“Indemnitee”).
OFFICE LEASE KILROY REALTY PACIFIC CORPORATE CENTER KILROY REALTY, L.P., a Delaware limited partnership, as Landlord, andOffice Lease • September 9th, 2015 • Anaptysbio Inc • Pharmaceutical preparations • California
Contract Type FiledSeptember 9th, 2015 Company Industry JurisdictionThis Office Lease (the “Lease”), dated as of the date (the “Effective Date”) set forth in Section l of the Summary of Basic Lease Information (the “Summary”), below, is made by and between KILROY REALTY, L.P., a Delaware limited partnership (“Landlord”), and ANAPTYSBIO, INC., a Delaware corporation (“Tenant”).
ANAPTYSBIO, INC. FOURTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • September 9th, 2015 • Anaptysbio Inc • Pharmaceutical preparations • California
Contract Type FiledSeptember 9th, 2015 Company Industry JurisdictionTHIS FOURTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is entered into as of July 13, 2015 by and among ANAPTYSBIO, INC., a Delaware corporation (the “Company”) and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”
COLLABORATION AND EXCLUSIVE LICENSE AGREEMENTCollaboration and Exclusive License Agreement • September 9th, 2015 • Anaptysbio Inc • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 9th, 2015 Company Industry JurisdictionThis COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT (the “Agreement”), effective as of March 10 , 2014 (the “Effective Date”), is made by and between (i) AnaptysBio, Inc., a Delaware corporation, having a place of business at 10421 Pacific Center Court, Suite 200, San Diego, California 92121 (“AnaptysBio”), and (ii) TESARO, Inc., a Delaware corporation, having a place of business at 1000 Winter Street, Suite 3300, Waltham, Massachusetts 02541 (“TESARO US”) and TESARO Development, Ltd., a Bermuda corporation, having its principal office at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (together with TESARO US, “TESARO”).
ANTIBODY GENERATION AGREEMENTAntibody Generation Agreement • September 9th, 2015 • Anaptysbio Inc • Pharmaceutical preparations • California
Contract Type FiledSeptember 9th, 2015 Company Industry JurisdictionThis ANTIBODY GENERATION AGREEMENT is entered into and effective as of December 2011 (the “Effective Date”), by and between ANAPTYSBIO, INC., a Delaware corporation (“AnaptysBio”), having its principal place of business at 10421 Pacific Center Court, Suite 200, San Diego, CA 92121, and CELGENE CORPORATION, a Delaware corporation (together with its subsidiaries and affiliates hereinafter collectively referred to as “Client”), having its principal place of business at 86 Morris Avenue, Summit, NJ 07901.
ANAPTYSBIO, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2015 • Anaptysbio Inc • Pharmaceutical preparations • California
Contract Type FiledSeptember 9th, 2015 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made effective from October 20, 2014 (the “Effective Date”) by and among ANAPTYSBIO, INC. (the “Company”) and Marco Londei (“CDO”). The Company and CDO are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
LICENSE AGREEMENT Between ANAPTYS BIOSCIENCES, INC. (ANAPTYS) and MEDICAL RESEARCH COUNCIL (MRC)License Agreement • September 9th, 2015 • Anaptysbio Inc • Pharmaceutical preparations • England
Contract Type FiledSeptember 9th, 2015 Company Industry JurisdictionThis Exclusive License Agreement (“Agreement”), is entered into as of the 30th day of August 2006 (hereinafter called “Effective Date”), by and between the MEDICAL RESEARCH COUNCIL (“MRC”), a UK government funded non-departmental body with principal offices at, 20 Park Crescent, London, W1B 1AL, United Kingdom and ANAPTYS BIOSCIENCES, INCORPORATED (“ANAPTYS”), a corporation organized under the laws of Delaware and having a principal place of business at 10931 North Torrey Pines Road, Suite 101, La Jolla, California 92037, United States of America.
CONSULTING AGREEMENTConsulting Agreement • September 9th, 2015 • Anaptysbio Inc • Pharmaceutical preparations • California
Contract Type FiledSeptember 9th, 2015 Company Industry JurisdictionThis Consulting Agreement (“Agreement”) is entered into as of May 1, 2015 (the “Effective Date”), between AnaptysBio, Inc. (“Company”), and David King (“Consultant”).